Platform Technology Partners »

Regeneron Pharmaceuticals shares owned by Platform Technology Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Platform Technology Partners from 13F filings

Historical chart of Platform Technology Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Platform Technology Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Platform Technology Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $259k 335 772.27

More positions owned by Platform Technology Partners

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Morgan Stanley Etf Trust Eaton Vance Shor (EVSD)
Federated Hermes Etf Trust Hermes Total Ret (FTRB)
Schwab Strategic Tr Us Dividend Eq (SCHD)
JPMorgan Chase & Co. (JPM)
Apollo Global Mgmt (APO)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Series Portfolios Tr Equable Shares H (HEDG)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Platform Technology Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals